Literature DB >> 32240960

Canal of Hering loss is an initiating step for primary biliary cholangitis (PBC): A hypothesis.

Neil D Theise1, James M Crawford2, Yasuni Nakanuma3, Alberto Quaglia4.   

Abstract

The origin and initiating features of PBC remain obscure despite decades of study. However, recent papers have demonstrated loss of canals of Hering (CoH) to be the earliest histologic change in liver biopsy specimens from patients with primary biliary cholangitis (PBC). We posit that CoH loss prior to significant inflammation or evidence of bile duct injury might be a very early, perhaps even an initiating lesion of PBC. As a potential target of inflammatory or toxic injury, CoH loss may initiate rather than follow the cascade of events leading to duct injury and loss and their sequelae. Toxins may be exogenous in origin, such as environmental toxins or drug exposures, or endogenous, resulting from genetic or epigenetic alterations in canalicular bile transporters upstream from the CoH. In turn, this hypothesis suggests that loss of CoH would lead to altered bile flow and composition injurious to downstream bile ducts, because bile composition has not been modulated by normal CoH physiologic functions or because, in the absence of CoH, canalicular fluid flow into the biliary tree is disrupted interfering with soluble trophic factors important for bile duct integrity. Regardless of the pathogenic mechanism causing CoH loss, only following such loss would the characteristic diagnostic findings of PBC become evident: damage to downstream interlobular and sub-lobular bile ducts. To the extent that the causal mechanisms for CoH loss can be identified, clinical identification (as through early identification of CoH loss) and intervention (depending on the inciting cause) may offer promise for treatment of this enigmatic disease.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Year:  2020        PMID: 32240960     DOI: 10.1016/j.mehy.2020.109680

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  4 in total

1.  Melancholé: The Dark Side of Bile Acids and Its Cellular Consequences.

Authors:  Weinan Zhou; Sayeepriyadarshini Anakk
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2022-02-14

2.  A randomized trial of safety and pharmacodynamic interactions between a selective glucocorticoid receptor antagonist, PT150, and ethanol in healthy volunteers.

Authors:  Claire Morice; Dewleen G Baker; Marguerite M Patel; Tracy L Nolen; Kayla Nowak; Shawn Hirsch; Thomas R Kosten; Christopher D Verrico
Journal:  Sci Rep       Date:  2021-05-10       Impact factor: 4.379

Review 3.  Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis.

Authors:  Samantha Sarcognato; Diana Sacchi; Federica Grillo; Nora Cazzagon; Luca Fabris; Massimiliano Cadamuro; Ivana Cataldo; Claudia Covelli; Alessandra Mangia; Maria Guido
Journal:  Pathologica       Date:  2021-06

4.  Apical Membrane Expression of Distinct Sulfated Glycans Is a Characteristic Feature of Ductules and Their Reactive and Neoplastic Counterparts.

Authors:  Hitomi Hoshino; Tomoya O Akama; Kenji Uchimura; Mana Fukushima; Akifumi Muramoto; Takeshi Uehara; Yasuni Nakanuma; Motohiro Kobayashi
Journal:  J Histochem Cytochem       Date:  2021-07-30       Impact factor: 4.137

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.